Comparison Chart Monte Rosa Therapeutics, Inc.
Stocks
GLUE
US61225M1027
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
01:30:00 03/10/2026 am IST
|
5-day change | 1st Jan Change | ||
| 10.50 USD | -6.75% |
|
-10.79% | -33.04% |
| 01/10 | Monte Rosa Therapeutics Announces Positive Data From GFORCE-1 Phase 1 Study Evaluating MRT-8102 | CI |
| 01/10 | Monte Rosa Therapeutics, Inc. - Special Call |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MONTE ROSA THERAPEUTICS, INC. | Other Biotechnology & Medical Research | -6.75% | -10.79% | -33.04% | +37.61% | -47.68% | 90Cr |  | | |
- Stock Market
- Stocks
- GLUE Stock
- Charts Monte Rosa Therapeutics, Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
